Please ensure Javascript is enabled for purposes of website accessibility
Home / Products / Antibody / Recombinant Antibody

Anti-COPA Antibody (R1Y76)

Catalog #:   RHE99001 Specific References (50) DATASHEET
Host species: Rabbit
Isotype: IgG
Applications: IHC, WB
Accession: P53621
Overview

Catalog No.

RHE99001

Species reactivity

Human, Mouse, Rat

Host species

Rabbit

Isotype

IgG

Clonality

Monoclonal

Tested applications

IHC: 1:100-1:200, WB: 1:1000-1:2000

Target

Coatomer subunit alpha, Xenopsin-related peptide, COPA, HEPCOP, Alpha-COP, HEP-COP, Alpha-coat protein

Concentration

1 mg/ml

Endotoxin level

Please contact with the lab for this information.

Purity

>95% by SDS-PAGE.

Purification

Protein A/G purified from cell culture supernatant.

Accession

P53621

Applications

IHC, WB

Form

Liquid

Storage buffer

0.01M PBS, pH 7.4, 0.05% BSA, 50% Glycerol, 0.05% Sodium azide.

Stability and Storage

Use a manual defrost freezer and avoid repeated freeze thaw cycles. Store at 4 ℃ for frequent use. Store at -20 ℃ for twelve months from the date of receipt.

Clone ID

R1Y76

Data Image
  • Western blot
    Western blot analysis of COPA expression in MCF7 cell lysate.
References

Single-centre comparison of non-familial, familial and monogenic lupus., PMID:40465409

French protocol for diagnosis and management of type 1 interferonopathies., PMID:40374386

The emerging concept of ANCA-associated vasculitis related to inborn errors of immunity., PMID:40294837

Antibiotic use attenuates response to immune checkpoint blockade in urothelial carcinoma via inhibiting CD74-MIF/COPA: revealing cross-talk between anti-bacterial immunity and ant-itumor immunity., PMID:38995167

Hexamerization: explaining the original sin of IgG-mediated complement activation in acute lung injury., PMID:38828725

Investigating SARS-CoV-2 Incidence and Morbidity in Ponce, Puerto Rico: Protocol and Baseline Results From a Community Cohort Study., PMID:38640475

COPA syndrome caused by a novel p.Arg227Cys COPA gene variant., PMID:37877458

A child with polyarthritis and chronic lung disease: a case report of ataxia-telangiectasia., PMID:37667293

Previous Dengue Infection among Children in Puerto Rico and Implications for Dengue Vaccine Implementation., PMID:37308104

A toddler with an unusually severe polyarticular arthritis and a lung involvement: a case report., PMID:36333696

Single-cell RNA Sequencing Analysis Reveals New Immune Disorder Complexities in Hypersplenism., PMID:35865544

Anti-TNF therapy for ulcerative colitis in Brazil: a comparative real-world national retrospective multicentric study from the Brazilian study group of IBD (GEDIIB)., PMID:35644668

Talaromyces marneffei infection associated with bronchiolitis obliterans in an HIV-negative child: a case report., PMID:35578185

Biological Treatments and Target Therapies for Pediatric Respiratory Medicine: Not Only Asthma., PMID:35242725

Risk of febrile neutropenia in very elderly patients aged ≥80 years receiving their first cycle of R-CHOP regimen: a nationwide real-world study in Japan., PMID:34978068

Clinical significance of TP53 mutations in adult T-cell leukemia/lymphoma., PMID:34405395

[Doxorubicin Hydrochloride Liposome-Based CHOP Regimen in the Initial Treatment of Elderly Patients with Diffuse Large B-Cell Lymphoma: A Retrospective Study]., PMID:34362493

Rheumatoid factor positive polyarticular juvenile idiopathic arthritis associated with a novel COPA mutation., PMID:33877315

Peripheral immune profile of children with Talaromyces marneffei infections: a retrospective analysis of 21 cases., PMID:33743629

IL-6 receptor blockade for allograft dysfunction after lung transplantation in a patient with COPA syndrome., PMID:33537146

Maternal and neonatal outcomes in 80 patients diagnosed with non-Hodgkin lymphoma during pregnancy: results from the International Network of Cancer, Infertility and Pregnancy., PMID:32945547

A methotrexate-associated lymphoproliferative disorder expressing CD10 and BCL6 with the IGH/CCND1 translocation., PMID:32851455

Gastric emphysema in chemosensitive gastric diffuse large B cell lymphoma., PMID:32519093

Lung Transplantation in a Patient with COPA Syndrome., PMID:32309005

VEDOLIZUMAB IN THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES: A BRAZILIAN OBSERVATIONAL MULTICENTRIC STUDY., PMID:31633731

[Diffuse alveolar hemorrhage in children]., PMID:31506159

Baricitinib in therapy of COPA syndrome in a 15-year-old girl., PMID:31449490

The impact of SOCS1 mutations in diffuse large B-cell lymphoma., PMID:31407320

Efficacy and safety of cyclophosphamide, doxorubicin, vincristine, and prednisone regimen with pegylated liposomal doxorubicin±rituximab in treating diffuse large B-cell lymphoma., PMID:31317691

Structure and allosteric coupling of type Ⅱ antitoxin CopASO., PMID:31101334

The effects of erythropoiesis-stimulating agents on the management of chemotherapy-induced anemia and tumor growth in diffuse large B-cell lymphoma patients., PMID:30973963

Geriatric screening tools predict survival outcomes in older patients with diffuse large B cell lymphoma., PMID:30443764

Primary bone lymphoma: tunisian multicentric retrospective study about 32 cases., PMID:30430499

Analysis of pulmonary features and treatment approaches in the COPA syndrome., PMID:29977900

Pulmonary extranodal marginal zone B-cell lymphoma of mucosa-associated lymph tissue: A case report and literature review., PMID:29519992

Type II toxin/antitoxin system ParESO /CopASO stabilizes prophage CP4So in Shewanella oneidensis., PMID:29411516

[Evaluation of Chemotherapy-Induced Nausea and Vomiting in Patients with Hematological Malignancies Using MASCC Antiemesis Tool(MAT)]., PMID:29362306

Anaplastic large cell lymphoma: pathology, genetics, and clinical aspects., PMID:29279550

FOXP1 expression is a prognostic biomarker in follicular lymphoma treated with rituximab and chemotherapy., PMID:29122756

Hepatitis B virus infection in an HBsAb-positive lymphoma patient who received chemotherapy: A case report., PMID:29095312

Type I interferon pathway activation in COPA syndrome., PMID:29030294

Detection of human T-cell lymphotropic virus type I-specific cytotoxic T-cells may predict treatment responses in adult T-cell leukemia/lymphoma patients., PMID:28656327

Addition of rituximab to CHOP-like chemotherapy in first line treatment of primary mediastinal B-cell lymphoma., PMID:28532396

Planar cell polarity genes Frizzled3a, Vangl2, and Scribble are required for spinal commissural axon guidance., PMID:27955617

The importance of Myd88 L265P mutation, clinical and immunohistochemical prognostic factors for the survival of patients with diffuse large B-cell non-Hodgkin lymphoma treated by immunochemotherapy in southeast Serbia., PMID:27837631

Early manifestation of mild cognitive impairment in B-cell non-Hodgkin's lymphoma patients receiving CHOP and rituximab-CHOP chemotherapy., PMID:27568029

[Clinical analysis of the character and prognostic factors of 23 cases of mantle cell lymphoma]., PMID:27431074

Continued Risk of Relapse Independent of Treatment Modality in Limited-Stage Diffuse Large B-Cell Lymphoma: Final and Long-Term Analysis of Southwest Oncology Group Study S8736., PMID:27382104

Thalidomide enhanced the efficacy of CHOP chemotherapy in the treatment of diffuse large B cell lymphoma: A phase II study., PMID:27129176

18F-FDG positron emission tomography scan findings in a case of rituximab-CHOP-induced pneumonitis., PMID:26905161

Datasheet

Document Download

Anti-COPA Antibody (R1Y76).pdf

 

$ 290
Product specifications
50 μg 290 100 μg 484

Contact Information

Order: order@antibodysystem.com

Mail: support@antibodysystem.com

Distributor list

For research use only. Not for human or drug use.

Need help with your order?

Find out more about placing an order here

Anti-COPA Antibody (R1Y76) [RHE99001]
Terms of sale Website terms of use Cookie policy Privacy
Copyright © 2025 AntibodySystem SAS. All Rights Reserved.            All Products are for Research Use Only